Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study (vol 59, 101981, 2023)

被引：0
|
作者：
Sun, Yuming [1 ,2 ,3 ,4 ,5 ,6 ]
Jin, Liping [1 ,2 ,3 ,4 ,5 ]
Dian, Yating [1 ,2 ,3 ,4 ,5 ]
Shen, Minxue [1 ,2 ,3 ,4 ,5 ,7 ]
Zeng, Furong [8 ]
Chen, Xiang [1 ,2 ,3 ,4 ,5 ]
Deng, Guangtong [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Peoples R China
[2] Natl Engn Res Ctr Personalized Diagnost & Therapeu, Elsevier, Egypt
[3] Furong Lab, Changsha, Hunan, Peoples R China
[4] Cent South Univ, Xiangya Hosp, Hunan Engn Res Ctr Skin Hlth & Dis, Hunan Key Lab Skin Canc & Psoriasis, Changsha, Peoples R China
[5] Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
[6] Cent South Univ, Xiangya Hosp, Dept Plast & Cosmet Surg, Changsha, Peoples R China
[7] Cent South Univ, Xiangya Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China
[8] Cent South Univ, Xiangya Hosp, Dept Oncol, Changsha, Hunan, Peoples R China
来源：
ECLINICALMEDICINE | 2023年 / 62卷
关键词：
D O I：
10.1016/j.eclinm.2023.102110
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study
    Sun, Yuming
    Jin, Liping
    Dian, Yating
    Shen, Minxue
    Zeng, Furong
    Chen, Xiang
    Deng, Guangtong
    ECLINICALMEDICINE, 2023, 59
  • [2] A Retrospective Analysis of Azvudine in Patients with COVID-19 and Pre-existing Cancer
    Li, Fangyu
    Zheng, Keao
    Qi, Xueyan
    Cui, Kaixia
    Yang, Jing
    Hao, Zhiying
    JOURNAL OF CANCER, 2024, 15 (08): : 2442 - 2447
  • [3] Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities
    Dian, Yating
    Meng, Yu
    Sun, Yuming
    Deng, Guangtong
    Zeng, Furong
    JOURNAL OF INFECTION, 2023, 87 (02) : E24 - E27
  • [4] A multicenter, real-world cohort study: effectiveness and safety of Azvudine in hospitalized COVID-19 patients with pre-existing diabetes
    Zhou, Yongjian
    Yang, Zecheng
    Zhang, Shixi
    Zhang, Donghua
    Luo, Hong
    Zhu, Di
    Li, Guangming
    Yang, Mengzhao
    Hu, Xiaobo
    Qian, Guowu
    Li, Guotao
    Wang, Ling
    Li, Silin
    Yu, Zujiang
    Ren, Zhigang
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [5] Impact of Pre-existing Oral Antidiabetic Treatment on Clinical Outcomes of COVID-19: a Retrospective Study
    Navale, A.
    Devangan, V.
    Goswami, A.
    Sahu, V.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [6] RELATIONSHIP BETWEEN PRE-EXISTING CONDITIONS IN COVID-19 PATIENTS AND INFLAMMATION
    Fritea, Luminita
    Sipponen, Maruzella
    Antonescu, Angela
    Miere, Florina
    Chirla, Razvan
    Vesa, Cosmin
    Cavalu, Simona
    Ganea, Mariana
    Horvath, Tunde
    Petchesi, Codruta
    Domuta, Maria
    PHARMACOPHORE, 2022, 13 (03): : 41 - 48
  • [7] RELATIONSHIP BETWEEN PRE-EXISTING CONDITIONS IN COVID-19 PATIENTS AND INFLAMMATION
    Fritea, Luminita
    Sipponen, Maruzella
    Antonescu, Angela
    Miere, Florina
    Chirla, Razvan
    Vesa, Cosmin
    Cavalu, Simona
    Ganea, Mariana
    Horvath, Tunde
    Petchesi, Codruta
    Domuta, Maria
    PHARMACOPHORE, 2022, 13 (04): : 41 - 48
  • [8] Pneumothorax/pneumomediastinum and pre-existing lung pathology in ventilated COVID-19 patients: a cohort study
    Kecskes, Gabriella
    Szabo, Albert
    Sutori, David
    Maroti, Peter
    Marovics, Gergely
    Molnar, Tamas F.
    JOURNAL OF THORACIC DISEASE, 2022, 14 (12) : 4733 - 4740
  • [9] Azvudine reduces the in-hospital mortality of COVID-19 patients: A retrospective cohort study
    Zong, Kaican
    Zhou, Hui
    Li, Wen
    Jiang, E.
    Liu, Yi
    Li, Shiying
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (11) : 4655 - 4660
  • [10] Azvudine reduces the in-hospital mortality of COVID-19 patients:A retrospective cohort study
    Kaican Zong
    Hui Zhou
    Wen Li
    E Jiang
    Yi Liu
    Shiying Li
    Acta Pharmaceutica Sinica B, 2023, (11) : 4655 - 4660
12345